Octreotide Long-Acting Release (LAR): A Review of its Use in the Management of Acromegaly

Author： McKeage K.   Cheer S.   Wagstaff A.J.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.22, 2003-01, pp. : 2473-2499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Octreotide Long-Acting Release (LAR): A Review of its Use in the Management of Acromegaly

By Yang Lily P.H.   Keating Gillian M.  

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1745-1769

Adis International

Access to resources Recommend Favorite

Long-Acting Risperidone: A Review of Its Use in Schizophrenia

By Tracy Swainston Harrison   Goa K.L.  

CNS Drugs, Vol. 18, Iss. 2, 2004-01 ,pp. : 113-132

Adis International

Access to resources Recommend Favorite

The efficacy of octreotide LAR (long acting release) treatment in patients with somatotropinoma, and mixed pituitary tumours

By Waśko Ryszard   Bolko Paweł   Owecki Maciej   Jaskuła Magdalena   Sowiński Jerzy  

Pharmacy World and Science, Vol. 26, Iss. 6, 2004-12 ,pp. : 324-327

Springer Publishing Company

Access to resources Recommend Favorite

Insulin Glargine: A Review of its Therapeutic Use as a Long-Acting Agent for the Management of Type 1 and 2 Diabetes Mellitus

By McKeage K.   Goa K.L.  

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1599-1624

Adis International

Access to resources Recommend Favorite

Olanzapine Long-Acting Injection: A Review of its Use in the Treatment of Schizophrenia

By Frampton James E.  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2289-2313

Adis International

Access to resources Recommend Favorite